BackgroundExcessive sugar intake increases the energy metabolic burden and the risk of cardiovascular disease (CVD). Patients on peritoneal dialysis (PD) absorb much more glucose than the World Health Organization recommends, but the link to CVD is unclear. ObjectiveTo identify the association between peritoneal glucose absorption, lipid metabolism, and CVD. MethodsWe applied generalized additive mixed-effects and mixed-effects Cox proportional hazard models to evaluate the impact of peritoneal glucose absorption on lipid profiles and CVD risk. We performed subgroup analyses by using protein intake (normalized protein nitrogen appearance [nPNA] and normalized protein catabolic rate [nPCR] were used to assess protein intake) and high-sensitivity C-reactive protein (hs-CRP). ResultsAfter multivariable adjustment, peritoneal glucose absorption per 10 g/d increase was associated with an increase in cholesterol of 0.145 (95% confidence interval [CI]: 0.086–0.204) mmol/L. No link with the total risk of CVD was observed; however, protein intake and hs-CRP levels affected the relationship between glucose absorption and CVD risk. Patients with values for nPNA and nPCR < 1.0 g/(kg∙d) were associated with a lower risk of CVD (hazard ratio [HR] 95% CI 0.68 (0.46–0.98)) with glucose absorption per 10 g/d increase. While patients with hs-CRP levels ≥ 3 mg/d or values for nPNA or nPCR ≥ 1.0 g/(kg∙d) were associated with a higher risk of CVD (HR 95% CI 1.32 (1.07–1.63); 1.31 (1.02–1.68)) for glucose absorption per 10 g/d increase. ConclusionsOur study found a positive correlation between peritoneal glucose absorption and lipid profiles. Increased glucose absorption was associated with a lower risk of CVD in lower protein intake patients, and a higher risk of CVD in higher hs-CRP or protein intake levels in patients on PD.